FR2772273B1 - Correction de la contracture de dupuytren - Google Patents

Correction de la contracture de dupuytren

Info

Publication number
FR2772273B1
FR2772273B1 FR9803320A FR9803320A FR2772273B1 FR 2772273 B1 FR2772273 B1 FR 2772273B1 FR 9803320 A FR9803320 A FR 9803320A FR 9803320 A FR9803320 A FR 9803320A FR 2772273 B1 FR2772273 B1 FR 2772273B1
Authority
FR
France
Prior art keywords
dupuytren
contract
correction
dupuytren contract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9803320A
Other languages
English (en)
Other versions
FR2772273A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADVANDE BIOFACTURES OF CURACAO
Original Assignee
ADVANDE BIOFACTURES OF CURACAO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADVANDE BIOFACTURES OF CURACAO filed Critical ADVANDE BIOFACTURES OF CURACAO
Publication of FR2772273A1 publication Critical patent/FR2772273A1/fr
Application granted granted Critical
Publication of FR2772273B1 publication Critical patent/FR2772273B1/fr
Priority to FR11C0033C priority Critical patent/FR11C0033I2/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
FR9803320A 1997-03-27 1998-03-18 Correction de la contracture de dupuytren Expired - Lifetime FR2772273B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR11C0033C FR11C0033I2 (fr) 1997-03-27 2011-08-18 Correction de la contracture de dupuytren

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/826,015 US6086872A (en) 1997-03-27 1997-03-27 Amelioration of dupuytren's disease

Publications (2)

Publication Number Publication Date
FR2772273A1 FR2772273A1 (fr) 1999-06-18
FR2772273B1 true FR2772273B1 (fr) 2003-04-25

Family

ID=25245473

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9803320A Expired - Lifetime FR2772273B1 (fr) 1997-03-27 1998-03-18 Correction de la contracture de dupuytren
FR11C0033C Active FR11C0033I2 (fr) 1997-03-27 2011-08-18 Correction de la contracture de dupuytren

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR11C0033C Active FR11C0033I2 (fr) 1997-03-27 2011-08-18 Correction de la contracture de dupuytren

Country Status (8)

Country Link
US (2) US6086872A (fr)
AU (1) AU733208B2 (fr)
DE (1) DE19813748A1 (fr)
DK (1) DK177324B1 (fr)
FR (2) FR2772273B1 (fr)
GB (1) GB2323530B (fr)
NO (1) NO981388L (fr)
SE (1) SE522723C2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US6022539A (en) * 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
GB0306165D0 (en) * 2003-03-18 2003-04-23 Delta G Ltd Medical treatment
KR100989267B1 (ko) * 2005-01-21 2010-10-20 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 유착 관절낭염을 치료하는 방법
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
ITPD20050207A1 (it) * 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2008100833A2 (fr) * 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production de collagénases recombinantes colg et colh dans escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
TWI395593B (zh) * 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
US20110229451A2 (en) * 2009-03-06 2011-09-22 Halozyme, Inc. Temperature sensitive mutants of matrix metalloproteases and uses thereof
US8702654B2 (en) * 2009-03-25 2014-04-22 John M. Agee Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
DK2632446T3 (en) 2010-10-30 2019-04-01 Univ Oxford Innovation Ltd TREATMENT OF DUPUYTRY CONTRACT
WO2012125948A1 (fr) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions et procédés de production de collagénases clostridiennes
DK2734216T3 (en) 2011-07-20 2018-11-19 Mediwound Ltd PROTEOLYTIC EXTRACT FROM BROMELAIN FOR TREATMENT OF CONNECTIVE TISSUE DISEASES
GB201119089D0 (en) 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders
NZ766918A (en) 2012-01-12 2023-03-31 Auxilium Int Holdings Inc Clostridium histolyticum enzymes and methods for the use thereof
US20150079069A1 (en) * 2012-04-30 2015-03-19 Elastomics Ab Methods for modification of tissues
US9636385B2 (en) 2012-10-24 2017-05-02 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
WO2014107745A1 (fr) 2013-01-07 2014-07-10 Halozyme, Inc. Métalloprotéases matricielles mutantes sensibles aux métaux et leurs utilisations
EP3834840A1 (fr) 2013-03-15 2021-06-16 BioSpecifics Technologies Corporation Produit et procédé de traitement des fibromes utérins au moyen de la collagénase purifiée
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
US11123280B2 (en) 2017-03-01 2021-09-21 Endo Ventures Limited Method of assessing and treating cellulite
US11473074B2 (en) 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
CA3157517A1 (fr) 2019-10-15 2021-04-22 The Johns Hopkins University Traitement de fibromes uterins a l'aide de collagenase purifiee

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5589171A (en) * 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase

Also Published As

Publication number Publication date
SE9800806L (sv) 1998-09-28
FR2772273A1 (fr) 1999-06-18
NO981388D0 (no) 1998-03-26
NO981388L (no) 1998-09-28
DK177324B1 (da) 2013-01-07
GB2323530A (en) 1998-09-30
SE522723C2 (sv) 2004-03-02
FR11C0033I1 (fr) 2011-09-23
SE9800806D0 (sv) 1998-03-12
USRE39941E1 (en) 2007-12-18
GB9805050D0 (en) 1998-05-06
US6086872A (en) 2000-07-11
AU5966198A (en) 1998-10-01
DE19813748A1 (de) 1998-10-01
FR11C0033I2 (fr) 2012-03-16
DK40398A (da) 1998-09-28
AU733208B2 (en) 2001-05-10
GB2323530B (en) 2001-10-10

Similar Documents

Publication Publication Date Title
FR2772273B1 (fr) Correction de la contracture de dupuytren
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
DE69833228D1 (de) Brückenzünder
DE69738464D1 (de) Photoempfindliche Zusammensetzung
BR9800705A (pt) Polimerização de ciclossiloxanos
EE200000365A (et) Bispidiini uued arütmiavastased ühendid
DE69607710T2 (de) Lichtempfindliche Zusammensetzung
DE69616104D1 (de) Lichtempfindliche Zusammensetzung
DE69817687D1 (de) Positiv-Fotoresist-Zusammensetzung
ID16838A (id) Komposisi dekafluoropentana
FI974091A0 (fi) Foerfarande foer foermedling av betalningsprestationer i Internet
DE59803356D1 (de) Schachtofen
DE29708814U1 (de) Wellengelenk
ATA189297A (de) Schachtofen
DE59812346D1 (de) Wellengelenk
ID17419A (id) Komposisi dekafluoropentana
KR950026510U (ko) 씽크대용 다리
FR2766727B1 (fr) Exerciseur
DE69804179T2 (de) Photoempfindliche Zusammensetzung
DE29715272U1 (de) Laufplanke
DE29710177U1 (de) Sanduhr
DE29701429U1 (de) Zahnbrücke
KR970013583U (ko) 경화방지용 캡
DE29715727U1 (de) Rauchabgebende Aufstellfigur
FI2777U1 (fi) Valoelementillä varustettu lista

Legal Events

Date Code Title Description
TP Transmission of property
CP Supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

CR Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)

Free format text: PRODUCT NAME: COLLAGENE CLOSTRIDIUM HISTOLYTICUM; REG. NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

CP Supplementary protection certificate (spc) filed

Effective date: 20110829

CT Granted supplementary protection certificate (spc) for medicine (eec regulation of 18 june 1992)

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Extension date: 20230317

Effective date: 20120316

AV Other action affecting the existence or the validity of an industrial property right

Effective date: 20120215

CY Supplementary certificate of protection granted (eec regulation of 18 june 1992)

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Extension date: 20230317

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20

SPAY Annual fee for spc paid [supplementary protection certificate]

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Year of fee payment: 1

Extension date: 20230317

SPAY Annual fee for spc paid [supplementary protection certificate]

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Year of fee payment: 3

Extension date: 20230317

SPAY Annual fee for spc paid [supplementary protection certificate]

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Year of fee payment: 4

Extension date: 20230317

SPAY Annual fee for spc paid [supplementary protection certificate]

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Year of fee payment: 5

Extension date: 20230317